Huang, Rui
Fan, Jian-Gao
Shi, Jun-Ping
Mao, Yi-Min
Wang, Bing-Yuan
Zhao, Jing-Min
Lu, Lun-Gen
Zhong, Bi-Hui
Zou, Zheng-Sheng
Xu, You-Qing
Ye, Yi-Nong
Liu, Long-Gen
Lin, Lian-Jie
Rao, Hui-Ying http://orcid.org/0000-0003-2431-3872
Wei, Lai
Article History
Accepted: 14 November 2022
First Online: 24 January 2023
Declarations
:
: H Rao has received speaking fees from Bristol-Myers Squibb, Gilead, and AbbVie. L Wei has received research support and/or consulting fees from Abbvie, Bristol-Myers Squibb, Gilead, Roche, and Novartis. R Huang, J Fan, J Shi, Y Mao, B Wang, J Zhao, L Lu, B Zhong, Z Zou, Y Xu, Y Ye, L Liu and L Lin certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
: This study was approved by the Institutional Review Board of Peking University People’s Hospital (2018PHB259-01). Written informed consent was obtained from each patient.
: Not applicable.
: Informed consent was obtained from all individual participants included in the study.